• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMO MANUFACTURING USA, LLC LIQUID OPTICS INTERFACE; OPHTHALMIC FEMTOSECOND LASER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMO MANUFACTURING USA, LLC LIQUID OPTICS INTERFACE; OPHTHALMIC FEMTOSECOND LASER Back to Search Results
Model Number 0180-1201
Medical Device Problem Code Contamination (1120)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/02/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Section d6a: if implanted, give date: not applicable, as liquid optics interface is not an implantable device.Section d6b: if explanted, give date: not applicable, as liquid optics interface is not an implantable device.Section h3: the liquid optics interface was not returned for evaluation; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc has been submitted.
 
Event or Problem Description
Customer reported debris on their liquid optics interface (loi).The issue was observed during docking/procedure activation.A new loi was required to complete the procedure.No patient injury was reported.
 
Additional Manufacturer Narrative
Device evaluation: the product was returned to the manufacturing site for evaluation.1 of the reported 1 opened loi received within original packaging confirming the reported lot number.A visual inspection of the returned product reveals some white residue on the lens.How and when the debris was introduced cannot be determined.The reported event is confirmed.Due to the open condition of the returned product and information stating that the product had been used, it cannot be determined at what point the observed white residue was introduced.The issue cannot be traced to the design, manufacturing, or labeling; product deficiency cannot be confirmed.However, based on the investigation results, product malfunction is confirmed.Manufacturing records review: the manufacturing records for the device were reviewed.The product was manufactured and released according to specification.All pertinent information available to johnson & johnson surgical vision, inc has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIQUID OPTICS INTERFACE
Common Device Name
OPHTHALMIC FEMTOSECOND LASER
Manufacturer (Section D)
AMO MANUFACTURING USA, LLC
510 cottonwood drive
milpitas CA 95035
Manufacturer Contact
somyata nagpal
31 technology drive
irvine, CA 92618
7142478552
MDR Report Key20791978
Report Number3012236936-2024-000316
Device Sequence Number6754661
Product Code OOE
UDI-Device Identifier05050474609778
UDI-Public(01)05050474609778(17)260502(10)24365627
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K170322
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 10/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/02/2026
Device Model Number0180-1201
Device Lot Number24365627
Was Device Available for Evaluation? Device Returned to Manufacturer
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/01/2024
Supplement Date Received by Manufacturer09/18/2025
Initial Report FDA Received Date11/27/2024
Supplement Report FDA Received Date10/15/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/03/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CATALYS SYSTEM SERIAL NUMBER: (B)(6).
Patient SexUnknown
-
-